Skip to main content
. 2023 Apr 5;12(3):727–749. doi: 10.1007/s40120-023-00467-8

Table 7.

Sponsorship of clinical trials

Number of continents Total
n (%)
Recruitment status Therapeutic purpose Repurposed
n (%)
Active
n (%)
Completed
n (%)
Other
n (%)
Symptomatic
n (%)
DMTs
n (%)
Academic centers 21 (52.5%) 5 (55.6%) 8 (38.1%) 8 (80%) 14 (46.7%) 7 (70%) 19 (76%)
Biopharma industry 17 (42.5%) 3 (33.3%) 13 (61.9%) 1 (10%) 15 (50%) 2 (20%) 5 (20%)
Public–private partnership 2 (5%) 1 (11.1%) 0 1 (10%) 1 (3.3%) 1 (10%) 1 (4%)